Global Seirin Pyonex Needles Market Strategic Research Report

Scope of the Report

The global Seirin Pyonex Needles market size is predicted to grow from US$ 551 million in 2025 to US$ 971 million in 2032; it is expected to grow at a CAGR of 7.8% from 2026 to 2032.

Seirin Pyonex Needles refer to disposable sterile intradermal needle devices developed and manufactured by Seirin Corporation of Japan, belonging to the category of micro-needles within traditional Chinese acupuncture instruments. Their core characteristics lie in the extremely short needle body and the needle handle pre-attached to a medical microporous adhesive tape. By shallow insertion into the intradermal layer and retention for several hours to days, they achieve sustained and gentle acupoint stimulation. From an industry perspective, this product is a typical outcome of the deep integration of traditional acupuncture therapy with modern precision manufacturing technology. In 1978, Seirin Corporation pioneered the global development of disposable sterile acupuncture needles, launched its press needle product in 2004, and established a representative office in China in 2013 to enter the Chinese market. Its patented sealed plastic structure enables aseptic operation where the operator never contacts the needle tip, and the product has obtained market access certifications from major global authorities including the US FDA, EU CE, and China's NMPA, with sales reaching over 40 countries and regions worldwide. According to the US FDA GUDID database, the product has GMDN code 34175, defined as a slender sharp instrument used to stimulate peripheral nerves to produce therapeutic effects, with FDA product code MQX. In China, its registration certificate number is Guoxie Jinzhu 20162201259, valid until 2026, with the National Medical Products Administration's latest approval document in September 2025 confirming its continued registration validity.

Market Development Opportunities and Key Drivers

In 1978, Seirin Corporation pioneered the global development of disposable sterile acupuncture needles, fundamentally changing the cross-infection risks associated with needle reuse. Over the following forty-plus years, the company continuously advanced automated and unmanned production processes. In 2017, the China Economic and Social Council disclosed that Seirin's production workshop had achieved unmanned automation, with quality surpassing that of Chinese enterprises. Seirin holds multiple patents, and its products have entered over 40 countries and regions worldwide, holding a domestic market share exceeding 70 percent in Japan while also occupying a dominant position in premium markets such as Europe and North America.

Market Challenges and Risks

Seirin's success reflects the collective predicament of China's domestic acupuncture needle industry. In 2017, the People's Political Consultative News reported that nearly all acupuncture needles used globally a decade prior were made in China, yet by 2017, Chinese manufacturing accounted for less than one-third of the global market, with production capacity lagging behind South Korea and quality lagging behind Japan. Seirin of Japan employs unmanned, automated processes, while Chinese companies such as Huatuo and Jiajian remain in a semi-mechanized state. The ISO standard for disposable sterile acupuncture needles, drafted under China's leadership, had its technical parameters made publicly available, allowing Japanese and South Korean companies to master the technical specifications and leverage WTO liberalization policies to capture market share. Foreign enterprises enjoy tax incentives, while domestic traditional companies lack access to dedicated funding channels. Currently, Seirin products are priced at 12 yuan per unit in winning bids at tertiary hospitals such as those in Shenzhen and Beijing, still occupying a premium price tier.

Downstream Demand Trends

A 2025 study from Lanzhou University First Hospital demonstrated that press needles significantly reduce the incidence of moderate to severe postoperative pain within 72 hours following gastric endoscopic submucosal dissection. Research published in Guangzhou Medical Journal confirmed that the combination of wrist-ankle acupuncture and press needles achieved a total effective rate of 92.5 percent in treating postherpetic neuralgia. The Chinese Journal of General Practice reported that press needles combined with Vitamin D therapy achieved a total effective rate of 90.0 percent in children with autism spectrum disorder. A study in the Journal of Practical Clinical Medicine showed that press needle therapy combined with intratympanic injection effectively alleviated inflammatory responses and improved inner ear blood circulation in the treatment of sudden sensorineural hearing loss. Seirin products continue to be procured through ongoing tenders at multiple tertiary hospitals in Shenzhen and Beijing, demonstrating stable clinical demand.

Regional Trends

Seirin of Japan, leveraging its unmanned production technology, occupies the premium segment of the global market, holding a domestic market share exceeding 70 percent and exporting to over 40 countries and regions. South Korean brands such as Dongbang and Haenglim occupy the mid-tier market, while Chinese acupuncture needle products largely remain at the lower end. In the Chinese market, Seirin established its representative office in 2013 and obtained its NMPA registration certificate in 2016. Its products have entered the procurement catalogs of tertiary hospitals including Beijing Chaoyang Hospital and Shenzhen Second People's Hospital, with a winning bid price of 12 yuan per unit, establishing a clear price differentiation from domestic brands. The increasingly stringent regulation of acupuncture needle production in China provides a more favorable market environment for compliant enterprises such as Seirin.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Seirin Pyonex Needles market?

What factors are driving Seirin Pyonex Needles market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Seirin Pyonex Needles market opportunities vary by end market size?

How does Seirin Pyonex Needles break out by Type, by Application?

This report presents a comprehensive overview of the global Seirin Pyonex Needles market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Grain-Type Needle
• Thumbtack-Type Needle

Segment by Needle Length

• Ultra-Short Type
• Short Type
• Medium Type

Segment by Needle Diameter

• 0.11mm Type
• 0.15mm Type
• 0.17mm Type
• 0.20mm Type

Segment by Application

• Pain Management
• Postoperative Care
• Otolaryngology

Segment by Application

• Body Acupoint Needle
• Ear Acupoint Needle

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Seirin Pyonex Needles market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Body Acupoint Needle, Ear Acupoint Needle evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact